China National Biotechnology (China)

China National Biotechnology (China), commonly known as CNBG, is a biopharmaceutical company headquartered in Beijing, China. It is the core biological-products and vaccine platform of the state-owned China National Pharmaceutical Group (Sinopharm). The company's activities span research, development, manufacturing and distribution of vaccines, blood products, and other biological medicines, serving public-health programs and commercial markets in China and abroad. CNBG is best known internationally for its role in vaccine development and supply, including COVID-19 vaccines developed under the Sinopharm umbrella. Its portfolio covers a broad range of preventive and therapeutic biologicals, and its affiliated institutes and production sites form one of the largest biological-products networks in China. As a Sinopharm subsidiary, CNBG operates within a state-owned enterprise structure and is not separately listed on a stock exchange. Its official website is cnbg.com.cn.

China National Biotechnology (China), or CNBG, is a Beijing-based company within China's state-owned pharmaceutical system. It forms the biological-products and vaccine core of the China National Pharmaceutical Group, known as Sinopharm. The group structure places CNBG alongside other Sinopharm units engaged in pharmaceutical distribution, manufacturing and research. CNBG's operations are organized around vaccines, blood products and related biological medicines. Its affiliated institutes and production facilities give it a broad manufacturing and research footprint in China. The company gained wider international recognition through its involvement in vaccine development and supply, particularly during the COVID-19 pandemic when vaccines developed under the Sinopharm umbrella were deployed in China and exported to multiple countries. As a subsidiary of Sinopharm, CNBG is part of a state-owned enterprise and is not separately listed. Its official web presence is at cnbg.com.cn.

State-owned biopharmaceutical platform focused on vaccines and blood products under Sinopharm.

• Vaccines

• Blood products

• Biological medicines

1. 1China National Biotechnology (China) — Wikidatawikidata.org
2. 2China National Biotechnology official websitecnbg.com.cn